Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy

NCT00707655 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped The decision is based on company re-evaluation of indications to be pursued within SCCHN

Conditions

Interventions

Sponsor

Genmab